Abstract
The in vitro effect of tedisamil on the specific activity and kinetic parameters of the sarcolemmal (Na,K)-ATPase as well as its ex vivo effect on the (Na,K)-ATPase in the isolated, perfused rat hearts was determined. Five μmol/l of tedisamil was added 5 min before the onset of 30 min global normothermic ischemia followed by 10 min reperfusion. At the conditions of its maximal cardioprotective effect (heart rate reduction, improved postischemic recovery of left ventricular developed pressure), the hearts were immediately used for isolation of sarcolemmal vesicles. In vitro, 1–100 μmol/l of tedisamil produced a concentration-dependent stimulatory effect on (Na,K)-ATPase activity, with a peak seen at 20 μmol/l (p < 0.01), while Mg-dependent ATPase was almost unchanged. Kinetic analysis revealed a significant increase in the affinity of the Na-binding sites on ATPase molecule at 20 μmol/l of tedisamil. These biochemical findings were confirmed by cytochemistry. Moreover, ex vivo experiments revealed that tedisamil rendered the sarcolemmal (Na,K)-ATPase activity to be a more resistant to detrimental effects of ischemia. In conclusion, the cardioprotective action of tedisamil was accompanied with a better preservation of the specific activity of (Na,K)-ATPase.
Similar content being viewed by others
References
Shou N, Antel J, Bruckner R, Messinger J, Franke R, Gruska A: Synthesis, pharmacological characterization and quantitative structureactivity relationship analysis of 3,7,9,9-tetraalkylbispidine: Derivatives with specific bradycardiac activity. J Med Chem 41: 318–331, 1998
Bray K, Oast U: Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulphate in rat isolated aorta. Naunym Schmied Arch Pharmacol 345: 24–31, 1992
Wettwer E, Himmel HM, Amos CJ, Li Q, Metzger F, Ravens N: Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes. Br J Pharmacol 125: 659–666, 1998
Dzimiri NN, Fricke U, Klan W: Influence of derivation on the lipophilicity and inhibitory action of cardiac glycosides on Na,K-ATPase. Br J Pharmacol 91: 31–38, 1987
Džurba A, Vrbjar N, Breier A, Ziegelhöffer A: The membrane effect of Benfluron: Modulation of the heart sarcolemmal (Na,K)-ATPase and Mg-ATPase activities. Gen Physiol Biophys 15: 71–75, 1996
Vrbjar N, Džurba A, Ziegelhöffer A: Enzyme kinetics and the activation energy of (Na,K)-ATPase in ischaemic hearts: Influence of the duration of ischaemia. Gen Physiol Biophys 13: 405–411, 1994
Tsuchiya K, Horie M, Haruna T, Ai T, Mishimoto T, Fujiwara H, Sasayama S: Functional communication between cardiac ATP-sensitive potassium channel and Na/K-ATPase.J Cardiovasc Electrophysiol 9: 415–422, 1998
RavingerováT, Wu S, Pancza D, Džurba A, Ziegelhöffer A, Parrat J: Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: Relevance to ischemic preconditioning. Exp Clin Cardiol 2: 19–24, 1997
Pitts B: Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. J Biol Chem 254: 6233–6235, 1979
Taussky H, Schorr E: A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202: 675–685, 1953
Lowry O, Rosebrough N, Farr A, Randall R: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951
Slezák J, OkruhlicováL, TribulováN, Schulze W, Dhalla NS: Renaissance of cytochemical localization of membrane ATPases in the myocardium. Mol Cell Biochem 147: 169–172, 1995
Shinmura K, Tani M, Hasegawa H, Nakamura Y: Effect of E-4031, a class III antiarrhythmic drug on ischemia and reperfusion-induced arrhythmias in isolated rat hearts. Jpn Heart J 39: 183–197, 1998
Mitrovic V, Oehm E, Strasser R, Schlepper M, Pitschner H: Hemodynamic, antiischemic, and neurohumoral effects of the new potassium channel blocking agent tedisamil in patients with coronary artery disease. Ztsch Kardiol 85: 961–972, 1996
Kramer J, Owens K, Weglicki W: Cardiac sarcolemmal (Na,K)-ATPase: Combined effect of propranolol and arachidonyl CoA. Am J Physiol 244: 4738–4742, 1983
DÓurba A, Ziegelhöffer A, SchmidtováL, Breier A, Vrbjar N, Okoli anýJ: Exaprolol as modulator of heart sarcolemmal (Na, K)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzyme. Gen Physiol Biophys 4: 257–264, 1985
Džurba A, Bárta E, Styk J, Okoli á ny J, Ziegelhöffer A: The influence of exaprolol upon the ischemic rat heart and its interaction with sarcolemmal (Na,K)-ATPase. Physiol Bohemoslov 38: 29–39, 1989
Džurba A, Vrbjar N, Ziegelhöffer A: Nitrendipine modulates the sodium binding site of cardiac (Na,K)-ATPase. Life Sci 52: 1175–1179, 1993
Džurba A, Ziegelhöffer A, Vrbjar N, Styk J, Slezák J: Estradiol modulates the sodium pump on the heart sarcolemma. Mol Cell Biochem 176: 113–118, 1997
Berger F, Borchard U, Hafner D, Putz I, Weis TM: Effect of 17 betaestradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmied Arch Pharmacol 356: 788–796, 1998
Džurba A, Ziegelhöffer A, Breier A, Vrbjar A, Szekeres L: Increase activity of sarcolemmal (Na,K)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience 2: 7–10, 1991
RavingerováT, Styk J, Tré gerováV, Pancza D, Slezák J, TribulováN, Ziegelhöffer A, Pissarek M, Szekeres L: Protective effect of 7-oxoprostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol 86:245–253, 1991
Ziegelhöffer A, Ravingerova T, Styk J, ŠbokováJ, WaczulikováI, Breier A, Džurba A, Volkovova K, Čársky J, TureckýL: Mechanism that may be involved in calcium tolerance of the diabetic heart. Mol Cell Biochem 176: 191–1987, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Džurba, A., Ziegelhöffer, A., Okruhlicová, L. et al. Salutary effect of tedisamil on post-ischemic recovery rat heart: Involvement of sarcolemmal (Na,K)-ATPase. Mol Cell Biochem 215, 129–133 (2000). https://doi.org/10.1023/A:1026583523041
Issue Date:
DOI: https://doi.org/10.1023/A:1026583523041